drugset / Trial / NCT01077453
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized phase I trial studies the side effects and the best dose of letrozole in preventing breast cancer in healthy postmenopausal women at high risk for breast cancer. Chemoprevention is the use of drugs to keep breast cancer from forming or coming back. The use of letrozole may keep cancer from forming in healthy postmenopausal women at high risk for breast cancer.
Timeline
- Start
- 2010-03
- Primary completion
- 2014-06
- Completion
- —
Outcome
Met primary endpoint
paper We conclude that low and intermittent doses of letrozole are not inferior to standard dose in estrogen suppression PMID 26667449 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 0.25 mg | Oral |
| Subject | Letrozole | Other / unclassified | 1 mg | Oral |
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |